In a comprehensive retrospective study, Kusumesh et al. reported the efficacy and safety of MMC versus IFNα2b for the therapy of CIN in 51 eyes of 50 patients. The gene discussed is IFNA2; the disease is cervical squamous intraepithelial neoplasia.